Patient-derived tumour organoids will serve as a new model in which to identify personalised treatments for patients with advanced bowel cancer, Australian researchers say. Organoids are tissue cultures grown in vitro from stem cells, which self-organise to replicate aspects of the function and structure of an organ in miniature. Medical oncologist Professor Peter Gibbs, from ...
Already a member?
Enter your email to keep reading.